Press release
Denosumab Market Size, Share, Trends, Insights And Forecast To 2033
Denosumab Market share
According to The Business Research Company's, The denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to clinical trials and research advancements, FDA approvals and regulatory milestones, growing awareness of bone health, strategic partnerships and marketing initiatives.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/denosumab-global-market-report
Market Drivers and Trends:
The increasing prevalence of osteoporosis is expected to propel the growth of the denosumab market going forward. Osteoporosis is a medical condition where the bones become weak, resulting in lower bone density and a higher risk of fractures. Denosumab is used to treat osteoporosis by stopping bone resorption through the targeting of the RANK ligand. For instance, In December 2023, according to a report published by the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, osteoporosis contributed to 2,366 deaths, or 6.5 deaths per 100,000 population in 2021, representing 1.4% of all deaths. Further, in 2021-22, there were 9,500 hospitalizations with a principal diagnosis of osteoporosis (89 hospitalizations per 100,000 population) for people aged 45 and over. Therefore, the increasing prevalence of osteoporosis is driving the growth of the denosumab market.
Major companies operating in the denosumab market are increasing their focus on introducing innovative solutions, such as first-line treatments for osteoporosis, to gain a competitive edge in the market. First-line treatment for osteoporosis refers to the initial or primary therapeutic approach recommended by healthcare professionals when managing individuals diagnosed with osteoporosis. For instance, in November 2022, Boan Biotech, a China-based biotechnology company, received approval from China's National Medical Products Administration (NMPA) for its denosumab biosimilar, Boyoubei, making it the first Chinese company to develop a denosumab injection. It is also being developed for markets outside of China, including Europe and the United States, with plans for global marketing. The drug has been recommended as a first-line treatment for osteoporosis in various treatment guidelines. The medication has the potential to dramatically lower the risk of hip, non-vertebral, and vertebral fractures in this patient population. Additionally, Boyoubei is the first biosimilar to Prolia (the originator of denosumab) approved for marketing in the world.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13835&type=smp
Major Key Players of the Market:
Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Limited, Mylan N.V., Sandoz International GmbH, Daiichi Sankyo Company Limited, Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Celltrion Inc., Amneal Pharmaceuticals Inc, Cadila Healthcare Limited, Lupin Limited, Biocon Limited, Torrent Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Ajanta Pharma Limited
Denosumab Market 2024 Key Insights:
• The denosumab market is expected to grow to $5.06 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%.
• Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence
• Emphasis On First-Line Denosumab Treatments For Osteoporosis
• North America was the largest region in the denosumab market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13835&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (https://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Denosumab Market Size, Share, Trends, Insights And Forecast To 2033 here
News-ID: 3683772 • Views: …
More Releases from The Business research company
Competitive Landscape: Key Market Leaders and Emerging Participants in the Ultra …
The demand for ultra pure water is on a sharp rise, driven by its critical role across multiple high-tech and industrial sectors. As industries continue to advance, ensuring the availability of water free from contaminants becomes increasingly vital. Let us explore the current market outlook, key players, emerging trends, and segment details shaping the ultra pure water market's future.
Expected Market Size and Growth Outlook for Ultra Pure Water
The ultra…
Future Perspectives: Key Trends Shaping the Styrene-Petrochemicals Market Up to …
The styrene-petrochemicals sector is positioned for steady expansion in the coming years, driven by diverse industrial demands and evolving market trends. Understanding the current landscape, key players, and emerging innovations sheds light on the future trajectory of this important chemical market.
Expected Growth and Market Size of the Styrene-Petrochemicals Industry
The styrene-petrochemicals market is projected to reach a value of $82.11 billion by 2029, growing at a compound annual growth rate…
Segmentation, Main Trends, and Competitive Overview of the Silicone Market
The silicone market is poised for significant expansion over the coming years, driven by various technological and environmental factors. This sector is rapidly evolving to meet the rising demand across multiple industries, fueled by innovations and sustainability trends. Let's explore the market's size, key players, growth drivers, emerging trends, and segmentation to understand the future outlook better.
Projected Expansion of the Silicone Market by 2029
The silicone market is expected to…
Competitive Landscape: Leading Companies and New Entrants in the Printing Inks M …
The printing inks market is on a steady upward path, driven by evolving technological innovations and growing demands from various industries. As the need for sustainable and efficient printing solutions increases, this sector is poised for significant expansion in the coming years. Below is a detailed overview of the market size, key players, trends, and segmentation shaping the future of printing inks.
Expected Market Size and Growth Prospects of the Printing…
More Releases for Denosumab
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Strategic Insi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Denosumab Market Size By 2025?
The market for denosumab has seen significant expansion in recent times. The growth is expected to rise from $3.27 billion in 2024 to $3.67 billion in 2025, portraying a compound annual growth rate (CAGR) of 12.1%. The increase during the…
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: A Key Driver P …
The Denosumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Denosumab Market Size and Its Estimated Growth Rate?
The market size of denosumab has seen a fast-paced expansion in the past few years. It is projected to surge from $3.27 billion in…
Denosumab Market Growth Fueled By Rising Osteoporosis Prevalence: Major Factor i …
How Will the Denosumab Market Grow, and What Is the Projected Market Size?
The denosumab market is expected to grow from $3.27 billion in 2024 to $3.7 billion in 2025, at a CAGR of 13.1%. Clinical trials, research advancements, and growing awareness of bone health are key drivers.
The denosumab market is expected to grow rapidly, reaching $5.59 billion by 2029, with a CAGR of 10.9%. This growth is attributed to the…
Denosumab Market Key Trends, Insights, Analysis 2024-2033: A Comprehensive Repor …
"The new report published by The Business Research Company, titled "" Denosumab Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023…
Denosumab Global Market Analysis, Trends, Growth, Research And Forecast 2033
The denosumab market size has grown rapidly in recent years. It will grow from $2.89 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to clinical trials and research advancements, FDA approvals and regulatory milestones, growing awareness of bone health, strategic partnerships and marketing initiatives.
The denosumab market size is expected to see…
Denosumab Market Report, Size, Share And Analysis 2024-2033
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Denosumab Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing…
